In general, adenocarcinomas affect a younger population of women regardless of whether they were exposed to
diethylstilbestrol (DES) in utero.
The development of cervical and vaginal adenosis as a result of
diethylstilbestrol exposure in utero.
Csaba G, Inczefi-Gonda A, Dobozy O (1986) Hormonal imprinting by steroids: a single neonatal treatment with
diethylstilbestrol or allylestrenol gives rise to a lasting decrease in the number of rat uterine receptors.
4) Selected item from the FDA drug bulletin-november 1971:
diethylstilbestrol contraindicated in pregnancy.
Medical castration of males with megestrol acetate and small doses of
diethylstilbestrol.
Trismethoxy resveratrol and
diethylstilbestrol dipropionate were not ionizable in negative mode.
Menstrual and reproductive characteristics of women whose mothers were exposed in utero to
diethylstilbestrol (DES), International Journal of Epidemiology, 2006, 35(4):862-868.
The drug DES -
diethylstilbestrol - has been linked to a dramatic increase in the risk of breast cancer in the daughters of mothers prescribed the drug.
Research shows women over 40 whose mums took DES -
diethylstilbestrol - are almost twice as likely to develop breast cancer.
The theory, published in the British Medical Journal, blames the amount of
diethylstilbestrol they experienced in the womb.
DES Action Canada was formed as a result of problems with the drug
diethylstilbestrol (DES), which was prescribed to an estimated 200,000 to 400,000 pregnant women across Canada between 1941 and 1971 in the mistaken belief that it prevented miscarriage.
In obstetrics and gynecology alone examples where errors occur include using X-rays for pregnancy diagnosis, the use of
diethylstilbestrol, a cancer-causing drug to prevent mis-carriage, and the history, of implanting large numbers of embryos to boost success rates in TVF).
